Display options
Share it on

Sultan Qaboos Univ Med J. 2011 Feb;11(1):104-7. Epub 2011 Feb 12.

VIPoma Crisis: Immediate and life saving reduction of massive stool volumes on starting treatment with octreotide.

Sultan Qaboos University medical journal

Omayma Elshafie, Christopher Grant, Aisha Al-Hamdani, Rajeev Jain, Nicholas Woodhouse

Affiliations

  1. Departments of Medicine and.

PMID: 21509215 PMCID: PMC3074686

Abstract

We report the case of a 57-year-old male physician who presented with a life threatening secretory and refractory diarrhoea of around 20 L/day. This was complicated by severe hypotension, hypokalaemia, hypercalcaemia, renal failure requiring dialysis, metabolic acidosis, cardiorespiratory arrest and ventilation for 12 days. His diarrhoea responded immediately to the first dose of a therapeutic trial of subcutaneous octreotide 100 mcg 8 hourly which was started on clinical grounds alone before any investigations were carried out. After one day he was extubated and his blood pressure returned to normal. When a functioning neuroendocrine tumour is suspected clinically, the use of octreotide can, as in this case, be life saving.

Keywords: Cardiopulmonary arrest; Case report; Chromogranin A; Diarrhoea; Neuroendocrine tumour; Octreotide; Oman; Pancreatic tumour; VIPoma

References

  1. Semin Oncol. 1987 Sep;14(3):282-91 - PubMed
  2. Am J Med. 1958 Sep;25(3):374-80 - PubMed
  3. J Gastrointest Surg. 2008 Feb;12(2):382-93 - PubMed
  4. Lancet. 1957 Dec 7;273(7006):1145-7 - PubMed
  5. J Exp Clin Cancer Res. 1998 Dec;17(4):389-400 - PubMed
  6. Surg Clin North Am. 1987 Apr;67(2):379-93 - PubMed
  7. N Engl J Med. 1983 Dec 15;309(24):1482-5 - PubMed
  8. Lancet. 1973 Jul 7;2(7819):14-6 - PubMed
  9. N Engl J Med. 1985 Jan 3;312(1):17-21 - PubMed
  10. Pancreas. 2004 Jan;28(1):93-7 - PubMed
  11. Hepatogastroenterology. 1999 Mar-Apr;46(26):679-90 - PubMed

Publication Types